From November 1992 to the present, 50 patients, most of whom suffering from severe cardiovascular, respiratory, neurological or hemocoagulative disorders, underwent laser prostatic ablation (VLAP) with Nd:YAG laser. Clinical and uroflowmetric follow-up at 6 weeks, 3 and 6 months showed significant improvement with low morbidity. We believe that VLAP is an alternative to TURP in patients with BPH. A better definition of techniques and overcoming the restrictions due to the learning curve could lead to even better results in the future.
HolrgreweH.L., MebustW.R., DowdJ.B.: Transurethral prostatectomy: practice aspects of the dominant operation in American Urology. J. Urol., 141: 248–253. 1989.
2.
DollH.A., BlackN.A., McPhersonK.: Mortality, morbidity and complication following transurethral resection of the prostate for benign prostatic hypertrophy. J. Urol., 147: 1566–1573, 1992.
3.
MebustW.K., HoltgreweH.L., CockerA.T.K.: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 partecipating institutions evaluating 3.885 patients. J. Urol., 141: 243–247, 1989.
4.
CostelloA.J., BowsherW.G., BoltonD.M.: Laser ablation of the prostate in patients with benign prostatic hyperplasia. Br. J. Urol., 69, 603–608, 1992.
5.
JohnsonD.E., PriceR.E., CromeensD.M.: Pathologic changes occuring in the prostate following transurethral laser prostatectomy. Las. Surg. Med., 12: 254–263, 1992.
6.
BarryM.J., FowlerF.J., O'LearyM.P.: The American Urological Association symptom index for benign prostatic hyperplasia, the Measurement Committee of the American Urological Association. J. Urol., 148: 1549–1557, 1992.
7.
ShambergA.M., TanseyL.A., BaghdassarianR.: The use of Neodymium:YAG laser in prostatectomy. J. Urol., 133: 3316, 1985.
8.
KaballinJ.N.: Laser prostatectomy performed with a right angle firing Neodymium:YAG laser fiber at 40 watts power setting. J. Urol., 150: 95–99, 1993.
9.
KabalinJ.N., GillH.S., BiteG., WolfeV.: Comparative study of laser versus elettrocautery prostatic resection: 18-months follow-up with complex urodynamic assessment. J. Urol., 15: 94–98, 1995.
10.
NarayanP., FournierG., Indudhara: Transurethral evaporation of the prostate (TUEP) with Nd:YAG laser, using a contact free beam technique: results in 61 patients with benign prostatic hyperplasia. Urology, 43 (6): 813–820, 1994.
11.
RavalliR., BrettschneiderN.: Nursing management of the laser prostatectomy patient. J. Endourol., 9 (2): 195–7, 1995.
12.
GibbonsR.P.: Surgical and laser treatment. In: Proceedings of the 3rd International Consultation on benign prostatic hyperplasia. Edited by CockettA.T.K., KhoursyS., AsoY., ChatelainC., DenisL., GriffithsK., MurphyG., Scientific Communication International Ltd., 10: 469–82, 1996.
13.
AnsonK., WatsonG.: The current status of the use of lasers in the treatment of benign prostatic iperplasia. Br. J. Urol., 75 (suppl. 1): 34–41, 1995.
14.
DixonC., MachiG., TheuneC., OlejniczakG., LeporH.: A prospective, double blind, randomised study comparing the safety, efficacy and cost of laser ablation of the prostate and transurethral prostatectomy for the treatment of BPH. J. Urol., 151: 229A, 1994.
